Stay updated on PH94B Nasal Spray in Public Speaking Anxiety Clinical Trial
Sign up to get notified when there's something new on the PH94B Nasal Spray in Public Speaking Anxiety Clinical Trial page.

Latest updates to the PH94B Nasal Spray in Public Speaking Anxiety Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedUpdated operating-status notice and version 3.2.0; removed version 3.1.0.SummaryDifference3%
- Check15 days agoChange DetectedChanged the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.SummaryDifference0.1%
- Check22 days agoChange DetectedAdded Estimated time labels for posting dates and removed exact labels. This shifts the user-facing metadata from fixed labels to estimated timing.SummaryDifference0.1%
- Check30 days agoChange DetectedStandardizes the trial page by introducing explicit product names and a single-dose formulation, adds defined SUDS and CGI-I outcomes with clear scoring, and clarifies the Visit 2–Visit 3 timeline and results-posting details; it also removes older granular dosing notes and the investigator’s name, shifting toward a more generic, modern protocol presentation.SummaryDifference12%
- Check37 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.2%
- Check44 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location, while removing specific geographic details and certain medical resources.SummaryDifference2%
Stay in the know with updates to PH94B Nasal Spray in Public Speaking Anxiety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PH94B Nasal Spray in Public Speaking Anxiety Clinical Trial page.